| Product NDC: | 44183-514 |
| Proprietary Name: | V-COF |
| Non Proprietary Name: | brompheniramine maleate, PHENYLEPHRINE HYDROCHLORIDE, and CARBETAPENTANE CITRATE |
| Active Ingredient(s): | 6; 25; 10 mg/5mL; mg/5mL; mg/5mL & nbsp; brompheniramine maleate, PHENYLEPHRINE HYDROCHLORIDE, and CARBETAPENTANE CITRATE |
| Administration Route(s): | ORAL |
| Dosage Form(s): | SUSPENSION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 44183-514 |
| Labeler Name: | Macoven Pharmaceuticals |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | |
| Marketing Category: | UNAPPROVED DRUG OTHER |
| Start Marketing Date: | 20100204 |
| Package NDC: | 44183-514-04 |
| Package Description: | 118 mL in 1 BOTTLE (44183-514-04) |
| NDC Code | 44183-514-04 |
| Proprietary Name | V-COF |
| Package Description | 118 mL in 1 BOTTLE (44183-514-04) |
| Product NDC | 44183-514 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | brompheniramine maleate, PHENYLEPHRINE HYDROCHLORIDE, and CARBETAPENTANE CITRATE |
| Dosage Form Name | SUSPENSION |
| Route Name | ORAL |
| Start Marketing Date | 20100204 |
| Marketing Category Name | UNAPPROVED DRUG OTHER |
| Labeler Name | Macoven Pharmaceuticals |
| Substance Name | BROMPHENIRAMINE MALEATE; CARBETAPENTANE CITRATE; PHENYLEPHRINE HYDROCHLORIDE |
| Strength Number | 6; 25; 10 |
| Strength Unit | mg/5mL; mg/5mL; mg/5mL |
| Pharmaceutical Classes |